These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 36434912)

  • 1. A review on structural, non-structural, and accessory proteins of SARS-CoV-2: Highlighting drug target sites.
    Jahirul Islam M; Nawal Islam N; Siddik Alom M; Kabir M; Halim MA
    Immunobiology; 2023 Jan; 228(1):152302. PubMed ID: 36434912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural insights into SARS-CoV-2 proteins.
    Arya R; Kumari S; Pandey B; Mistry H; Bihani SC; Das A; Prashar V; Gupta GD; Panicker L; Kumar M
    J Mol Biol; 2021 Jan; 433(2):166725. PubMed ID: 33245961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-Dimensional Visualization of Viral Structure, Entry, and Replication Underlying the Spread of SARS-CoV-2.
    Saville JW; Berezuk AM; Srivastava SS; Subramaniam S
    Chem Rev; 2022 Sep; 122(17):14066-14084. PubMed ID: 35863749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural biology of SARS-CoV-2.
    Zaidi AK; Dawoodi S
    Prog Mol Biol Transl Sci; 2024; 202():31-43. PubMed ID: 38237989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of Nonstructural Protein 1 from SARS-CoV-2.
    Clark LK; Green TJ; Petit CM
    J Virol; 2021 Jan; 95(4):. PubMed ID: 33234675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 Proteins: Are They Useful as Targets for COVID-19 Drugs and Vaccines?
    Mohammed MEA
    Curr Mol Med; 2022; 22(1):50-66. PubMed ID: 33622224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19.
    Yadav R; Chaudhary JK; Jain N; Chaudhary PK; Khanra S; Dhamija P; Sharma A; Kumar A; Handu S
    Cells; 2021 Apr; 10(4):. PubMed ID: 33917481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural understanding of SARS-CoV-2 virus entry to host cells.
    Le K; Kannappan S; Kim T; Lee JH; Lee HR; Kim KK
    Front Mol Biosci; 2023; 10():1288686. PubMed ID: 38033388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
    Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryo-EM analysis of the post-fusion structure of the SARS-CoV spike glycoprotein.
    Fan X; Cao D; Kong L; Zhang X
    Nat Commun; 2020 Jul; 11(1):3618. PubMed ID: 32681106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two Ligand-Binding Sites on SARS-CoV-2 Non-Structural Protein 1 Revealed by Fragment-Based X-ray Screening.
    Ma S; Damfo S; Lou J; Pinotsis N; Bowler MW; Haider S; Kozielski F
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural Basis of a Human Neutralizing Antibody Specific to the SARS-CoV-2 Spike Protein Receptor-Binding Domain.
    Yang M; Li J; Huang Z; Li H; Wang Y; Wang X; Kang S; Huang X; Wu C; Liu T; Jia Z; Liang J; Yuan X; He S; Chen X; Zhou Z; Chen Q; Liu S; Li J; Zheng H; Liu X; Li K; Yao X; Lang B; Liu L; Liao HX; Chen S
    Microbiol Spectr; 2021 Oct; 9(2):e0135221. PubMed ID: 34643438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
    Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
    Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-resolution structure and biophysical characterization of the nucleocapsid phosphoprotein dimerization domain from the Covid-19 severe acute respiratory syndrome coronavirus 2.
    Zinzula L; Basquin J; Bohn S; Beck F; Klumpe S; Pfeifer G; Nagy I; Bracher A; Hartl FU; Baumeister W
    Biochem Biophys Res Commun; 2021 Jan; 538():54-62. PubMed ID: 33039147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding COVID-19 via comparative analysis of dark proteomes of SARS-CoV-2, human SARS and bat SARS-like coronaviruses.
    Giri R; Bhardwaj T; Shegane M; Gehi BR; Kumar P; Gadhave K; Oldfield CJ; Uversky VN
    Cell Mol Life Sci; 2021 Feb; 78(4):1655-1688. PubMed ID: 32712910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural biology of SARS-CoV-2 and implications for therapeutic development.
    Yang H; Rao Z
    Nat Rev Microbiol; 2021 Nov; 19(11):685-700. PubMed ID: 34535791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status.
    Guo YR; Cao QD; Hong ZS; Tan YY; Chen SD; Jin HJ; Tan KS; Wang DY; Yan Y
    Mil Med Res; 2020 Mar; 7(1):11. PubMed ID: 32169119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of intrinsically disorder regions in non-structural proteins of SARS-CoV-2: New insights into drug and vaccine resistance.
    Anjum F; Mohammad T; Asrani P; Shafie A; Singh S; Yadav DK; Uversky VN; Hassan MI
    Mol Cell Biochem; 2022 May; 477(5):1607-1619. PubMed ID: 35211823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newly Emerged Antiviral Strategies for SARS-CoV-2: From Deciphering Viral Protein Structural Function to the Development of Vaccines, Antibodies, and Small Molecules.
    Zhang C; Yang M
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.